Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: A retrospective cost-effectiveness analysis

Huseyin Naci, Gregory De Lissovoy, Christopher Hollenbeak, Brian Custer, Axel Hofmann, William McClellan, Matthew Gitlin

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: A retrospective cost-effectiveness analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences